Tirzepatide, a recently approved medication, is generating significant buzz in the medical community as a potential treatment for both type 2 diabetes and weight loss . This unique drug works by stimulating two distinct receptors, GLP-1 and GIP, leading to enhanced glycemic management and substantial fat loss in research studies . While preliminary